- What is eConsent in clinical trials?
- Why is eConsent important in clinical research?
- Who typically benefits from eConsent in clinical trials?
- How does eConsent work?
- What is the difference between eConsent and traditional paper consent?
- What devices can be used for eConsent?
- Can eConsent be used in decentralized or remote clinical trials?
- What languages does eConsent support?
- Can participants review consent materials remotely?
- How can eConsent improve the patient experience?
- How does eConsent help clinical trial research sites?
- Is electronic consent accepted by regulators?
- What makes Suvoda eConsent different from other eConsent systems?
- How can sponsors or research sites get started with Suvoda eConsent?
-
What is eConsent in clinical trials?
eConsent is a digital system used to present informed consent information to clinical trial participants and collect their consent electronically. Instead of relying on paper documents, eConsent software can use interactive digital formats—such as videos, graphics, and structured content—to help participants understand the study before deciding whether to take part. The system also records and stores consent securely for regulatory documentation.
-
Why is eConsent important in clinical research?
Informed consent is a foundational requirement in clinical trials. Participants must clearly understand the study, its risks and benefits, and their rights before agreeing to participate.
Traditional paper consent forms can be long and difficult to navigate for patients. eConsent improves the process by presenting information in a clearer, more engaging way while creating a reliable digital record of consent.
eConsent is also important because it serves as a consent management solution, giving sites and sponsors real-time visibility into consent status and automated control across the trial. Rather than waiting on manual reporting or paper-based tracking, study teams can see at any moment who has consented, who is pending, and which version of the consent form each participant signed—supporting faster oversight and cleaner documentation.
-
Who typically benefits from eConsent in clinical trials?
eConsent is used by several stakeholders involved in running a clinical trial. Research sites use eConsent to present study information to participants, guide them through the consent process, and document consent electronically. Sponsors and CROs use eConsent to standardize consent workflows across studies, maintain oversight, and capture regulatory documentation properly. Participants use eConsent to review study information, ask questions, and provide informed consent using a digital device such as a tablet, computer, or smartphone.
-
How does eConsent work?
When preparing to participate in a clinical trial, a participant reviews study information on a digital device such as a tablet, computer, or smartphone. The system may include multimedia elements, knowledge checks, and guided navigation to support understanding of key concepts. After reviewing the information and discussing questions with the study team, the participant signs the consent electronically.
The system also supports “wet-ink” upload and print-and-sign, still allowing the system to capture when each form was signed and against which version, so sites and sponsors maintain real-time visibility into consent status regardless of signature method.
If the study is updated—for example, due to protocol amendments or new safety information—participants may be asked to review updated information and provide consent again. This reconsent process is managed within the same system, helping participants stay informed of relevant changes throughout the trial.
-
What is the difference between eConsent and traditional paper consent?
Traditional paper consent relied on printed documents that participants review and sign in person at a study site. While this approach is familiar, it has practical limitations: documents can be lengthy and difficult to navigate, tracking consent versions across a study requires manual effort, and there is no automated way for sites or sponsors to confirm consent status in real time.
eConsent replaces this process with a digital system that can present the same information in a structured, interactive format and collects the participant's signature electronically. The system automatically records which version of the consent form each participant signed and when, creating a reliable audit trail without manual tracking. For sites and sponsors, this means less administrative burden and greater real-time visibility into consent status across the study.
-
What devices can be used for eConsent?
eConsent can be accessed on a range of devices including tablets, desktop computers, laptops, and smartphones. Participants may use a device provided by the research site during a visit, or in some cases their own personal device if the study supports remote or bring-your-own-device (BYOD) consent workflows. The specific devices available will depend on the eConsent system and how the study is configured.
-
Can eConsent be used in decentralized or remote clinical trials?
Yes. eConsent is well suited to decentralized clinical trials (DCTs) and studies that include remote participation. Because participants can review consent materials on their own device at home, eConsent can remove the requirement for an in-person site visit solely for the purpose of obtaining consent. This makes it easier to enroll participants who live far from a study site or who have difficulty traveling.
In a decentralized trial, eConsent typically works alongside other digital tools such as eCOA for outcome data collection and remote patient support services. When these capabilities are part of the same platform, study teams can manage consent and participant activity in a connected environment rather than coordinating across multiple systems.
-
What languages does eConsent support?
eConsent systems can support multiple languages, which is important for sponsors running global or multinational clinical trials where participants may speak different languages or live in different regions.
Suvoda works with sponsors and sites to configure the eConsent system with the language requirements of each study, so that participants can review and understand consent information in their preferred language. For organizations with global trial programs, this is an important consideration when evaluating eConsent solutions.
-
Can participants review consent materials remotely?
Yes. eConsent systems can support remote review, allowing participants to read and explore consent materials at home or before arriving at a study visit. This can give participants more time to consider the information, discuss the study with family members or caregivers, and prepare questions for the research team.
-
How can eConsent improve the patient experience?
eConsent can make study information easier to understand by presenting it in a structured and interactive format.
Participants can move through the material at their own pace, revisit sections if needed, and access educational content that explains study procedures and expectations more clearly than a static document.
-
How does eConsent help clinical trial research sites?
eConsent can reduce administrative work and improve documentation management for sites. Digital consent systems help track consent versions, record timestamps, and maintain a clear audit trail. This makes it easier for sites to demonstrate compliance with study protocols and regulatory requirements.
eConsent also streamlines the reconsent process when studies are updated, enabling sites to efficiently distribute revised information, track completion, and maintain accurate records without relying on manual follow-up or paper-based workflows.
-
Is electronic consent accepted by regulators?
Yes. Regulatory authorities such as the FDA and other global agencies allow the use of electronic informed consent when it meets applicable regulatory and ethical requirements. eConsent systems must maintain appropriate security, identity verification, privacy, documentation, and audit trails to demonstrate that consent was obtained properly.
-
What makes Suvoda eConsent different from other eConsent systems?
Suvoda eConsent is part of the unified Suvoda Platform. This means the consent process can connect directly with other clinical trial workflows such as randomization with RTSM, eCOA, patient payments, travel coordination, and study management.
Because these capabilities operate within the same platform, participant information and study events can flow across systems without relying on multiple disconnected tools. Study teams can manage consent, participant activities, and related workflows within a single ecosystem, reducing operational complexity for sites and improving visibility for sponsors.
The approach also helps support a more streamlined participant experience. They can review consent materials and continue managing other study activities within the same connected environment instead of navigating separate systems.
-
How can sponsors or research sites get started with Suvoda eConsent?
Getting started generally involves working with the Suvoda team to configure consent materials, define study workflows, and align the system with protocol requirements and regulatory expectations.